Home

The effect of amniotic membrane extract on epithelialization and neovascularization in models of corneal damage

Written by Maltsev D.S., Rudko A.S., Kulikov A.N., Chernysh V.F.

  UDK: 617.713–001.37–089.843: 611.013.83 | Pages: 46–49 | Full text PDF | Open PDF 

Annotation:

.Objective. The aim of the study was to evaluate the effect of the human amniotic membrane extract (AME) on wound healing of the corneal epithelium of the corneal epithelium, as well as on epithelialization and vascularization of the cornea in the model of severe alkaline burn.
Methods. The toxicity of AME (at a concentration of 6.3 %) and its effect on the migration activity of corneal epithelial cells (at concentrations of 6.3, 0.63 and 0.063 %) were examined on a cell culture obtained from a donor material in a standard MTT-test and a wound test culture monolayer, respectively. The effect of AME (6.3 %) on epithelialization and neovascularization of the cornea was studied in the experimental model of a corneal burn and a limb 50 % in rabbits for 30 days.
Results. There were no statistically significant changes in the viability of the cell culture under the action of AME at a concentration of 6.3 %. After 48 hours in culture samples with the content of AME at concentrations of 6.3, 0.63 and 0.063 % and the control, the width of the monolayer wound was 433.0±130.3, 235.5±56.4, 159.5±100.0 and 132.5±53.2 μm. By the 30th day, the epithelialization area in control and treated with the use of AME animals was 21.2±10.2 and 99.5±0.4 %, respectively. A statistically significant increase in the area of corneal neovascularization with the use of AME as compared with the control was observed at the 7th (28.5±12.7 and 12.1±3.2 %) and 30th (81.9±18.1 and 43.3±4.7 %, respectively) day.
Conclusions. The results of the study demonstrate the dose-dependent inhibition of the migration of corneal epithelium cells under the influence of AME in vitro, without the cytotoxic effects of high extract concentrations on the cell culture, and the stimulation of the neovascularization of the cornea in a severe chemical burn model in vivo.

Links to authors:

D.S. Maltsev1, A.S. Rudko2, A.N. Kulikov1, V.F. Chernysh1
1 S.M. Kirov Military Medical Academy (6 Akademika Lebedeva St., St. Petersburg 194044 Russian Federation),
2 Branch No. 4 of the Military Hospital 439 (29b Zapadnaya St. Novosysoevka, Yakavlevskiy district, Primorskiy territory 692350 Russian Federation)


1. Sitnik G.V. Modern cellular biotechnology in ophthalmology. Amniotic membrane as a substrate for the cultivation of epithelial stem cells // Belarussian Med. J. 2006. Vol. 4, No. 4. P. 15–21.
2. Chernysh V.F., Boyko E.V. Burns of the eye – status challenges and new approaches. Moscow: GEOTAR-Media, 2017. 184 p.
3. Baum J. Thygeson lecture. Amniotic membrane transplantation: Why is it effective? // Cornea. 2002. No. 21. P. 339–341.
4. Bernas T., Dobrucki J. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes // Cytometry. Part A. 2002. Vol. 47, No. 4. P. 236–242.
5. Clare G.L., Suleman H., Bunce C. [et al.]. Amniotic membrane transplantation for acute ocular burns // Cochrane Database Syst. Rev. 2012. DOI: 10.1002/1465 1858.
6. Hao Y., Ma D.H., Hwang D.G. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane // Cornea. 2000. Vol. 19, No. 3. P. 348–352.
7. Kruse F.E. Diseases of the eye surface // Ophthalmol. 2003. Vol. 100, No. 11. P. 897–898.
8. Liu T. Amniotic membrane traps and induces apoptosis of inflammatory cells in ocular surface chemical burn // Mol. Vis. 2012. Vol. 18. P. 2137–2146.
9. Meller D. Pires R.T., Tseng S.C. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures // Br. J. Ophthalmol. 2002. Vol. 86, No. 4. P. 463–471.
10. Nabel E.G., Yang Z.Y., Plautz G. [et al.]. Recombinant fibroblast growth factor 1 promotes intimal hyperplasia and angiogenesis in arteries in vivo // Nature. 1993. Vol. 362, No. 6423. P. 844–846.
11. Ricciardelli G., Ceccuzzi R., Raneri M. [et al.]. Management of recurrent corneal ulcers: use of amniotic membrane // Eur. J. Ophthalmol. 2014. Vol. 24, No. 5. P. 793–796.
12. Slu G.D., Young A.L., Cheng L.L. Long-term symptomatic relief of bullous keratopathy with amniotic membrane transplant // Int. Ophtalmol. 2015. Vol. 35, No. 6. P. 777–783.
13. Thomas J.K., Lim J.J., Zabek N., Massee M. Cytokines in single layer amnion allografts compared to multilayer amnion/chorion allografts for wound healing // J. Biomedical Mat. Res. Part B. 2014. Vol. 103, No. 5. P. 1133–1140.
14. Tseng S. Evolution of amniotic membrane transplantation // Clin. Experiment. Ophthalmol. 2007. Vol. 35, No. 2. P. 109–110.
15. Yang M.K., Kim M.K., Kim D.M. Amniotic membrane transplantation for repair of a large intraoperative conjunctival defect during trabeculectomy // Ophthalmol. 2015. Vol. 29, No. 1. P. 73–74.

PUBLISHER: "MEDITSYNA DV"

Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.